Hospital topics · 2026
A Study Protocol for a Randomized Controlled Trial on the Development and Evaluation of a Mobile Application for Breast Cancer Survivors.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kaur Maninderdeep, Yadav Budhi S, Kaur Sukhpal, Dahiya Divya, Sharma Akhilesh, Ghoshal Sushmita, Kumar Ashok, Kumar Pramod
Аннотация
BACKGROUND: Evidence has shown that breast cancer self-management support from mobile apps can improve the quality of life of patients. While many breast cancer mobile applications exist, few applications have documented the process of developing an easy-to-use application from a patient's point of view.
OBJECTIVES: To develop a mobile application that is user-centered, context-specific and to evaluate its clinical effectiveness on quality of life and management of health problems of breast cancer survivors.
METHODS: The proposed research will be conducted in two phases; the first phase (Phase 1a) will be focused on the development of mobile app content. The pilot phase (Phase 1b), where a prototype of the application will be designed, and its usability will be evaluated. Finally, in the second phase (Phase 2), the clinical effectiveness of a mobile app in breast cancer survivors.
CONCLUSION: The findings of this proposed trial may provide a platform for telerehabilitation for breast cancer survivors in resource-limited settings. Furthermore, the findings of this study may pave the way for innovative approaches to healthcare delivery in India and other comparable contexts.
OBJECTIVES: To develop a mobile application that is user-centered, context-specific and to evaluate its clinical effectiveness on quality of life and management of health problems of breast cancer survivors.
METHODS: The proposed research will be conducted in two phases; the first phase (Phase 1a) will be focused on the development of mobile app content. The pilot phase (Phase 1b), where a prototype of the application will be designed, and its usability will be evaluated. Finally, in the second phase (Phase 2), the clinical effectiveness of a mobile app in breast cancer survivors.
CONCLUSION: The findings of this proposed trial may provide a platform for telerehabilitation for breast cancer survivors in resource-limited settings. Furthermore, the findings of this study may pave the way for innovative approaches to healthcare delivery in India and other comparable contexts.